| Literature DB >> 33167850 |
Jia Feng1, Hai-Jun Zhang1, Shu-Geng Wu1, Guang-Hai Qi2, Jing Wang3.
Abstract
BACKGROUND: Lower eggshell quality in the late laying period leads to economic loss. It is a major threat to the quality and safety of egg products. Age-related variations in ultrastructure were thought to induce this deterioration. Eggshell formation is a highly complex process under precise regulation of genes and biological pathways in uterus of laying hens. Herein, we evaluated the physical, mechanical and ultrastructure properties of eggshell and conducted RNA sequencing to learn the transcriptomic differences in uterus between laying hens in the peak (young hens) and late phase (aged hens) of production.Entities:
Keywords: Eggshell quality; Late laying period; Laying hen; Transcriptome; Ultrastructure; Uterus
Mesh:
Substances:
Year: 2020 PMID: 33167850 PMCID: PMC7654033 DOI: 10.1186/s12864-020-07177-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Comparison of chemical composition, physical and mechanical properties of eggshell between young (42 wk. of age) and aged hen groups (72 wk. of age)
| Items | Young hen | Aged hen | |
|---|---|---|---|
| Calcium content (mg/g) | 370.62 ± 19.72 | 344.68 ± 33.96 | 0.083 |
| Phosphorus content (μg/g) | 1.11 ± 0.12 | 1.00 ± 0.17 | 0.169 |
| Matrix protein content (mg/g) | 13.72 ± 1.18 | 13.32 ± 1.18 | 0.507 |
| Shell thickness (mm) | 0.37 ± 0.02 | 0.39 ± 0.02 | 0.234 |
| Egg weight (g) | 64.42 ± 0.54 | 65.83 ± 1.12 | 0.006 |
| Shell weight (g) | 6.37 ± 0.05 | 6.49 ± 0.10 | 0.008 |
| Shell ratio (%) | 9.89 ± 0.05 | 9.86 ± 0.04 | 0.244 |
| Breaking strength (N) | 46.32 ± 1.64 | 36.85 ± 2.74 | < 0.001 |
| Stiffness (N/mm) | 74.88 ± 1.91 | 75.39 ± 3.16 | 0.702 |
| Elastic modules (N/mm2) | 7636.34 ± 133.61 | 7583.75 ± 261.38 | 0.620 |
| Fracture toughness (N/mm3/2) | 573.11 ± 40.29 | 456.35 ± 38.75 | < 0.001 |
Data are the mean of 8 replicates with 24 eggs each (another 12 eggs of each replicate for the measurement of stiffness, elastic modules and fracture toughness)
Fig. 1The eggshell ultrastructure in young (a; 42 wk. of age) and aged hen groups (b; 72 wk. of age; scanning electron microscope images, magnification, 200×). The ultrastructural characteristics (c&d) of eggshell in young and aged hen groups. MW, mammillary width; MT, mammillary layer thickness; ET, effective layer thickness; TT, total thickness. Data are the mean of 8 replicates with 24 eggs each. Asterisk represents a significant difference (P < 0.05) between groups
Comparison of ultrastructural variations in mammillary layer of eggshell between young (42 wk. of age) and aged hen groups (72 wk. of age)
| Ultrastructural variation | Young hen | Aged hen | |
|---|---|---|---|
| Mammillae density | 224.53 ± 13.48 | 221.92 ± 11.80 | 0.686 |
| Confluence | 2.59 ± 1.04 | 2.97 ± 0.91 | 0.456 |
| Type B | 1.72 ± 0.76 | 1.94 ± 0.40 | 0.483 |
| Type A | 1.13 ± 0.13 | 1.16 ± 0.19 | 0.705 |
| Aragonite | 1.03 ± 0.09 | 1.16 ± 0.19 | 0.117 |
| Early fusion | 1.72 ± 0.62 | 2.59 ± 0.92 | 0.042 |
| Late fusion | 3.13 ± 1.13 | 4.22 ± 1.16 | 0.077 |
| Cuffing | 2.97 ± 1.39 | 3.28 ± 0.75 | 0.583 |
| Pitted | 1.13 ± 0.35 | 1.25 ± 0.46 | 0.554 |
| Caps | 2.66 ± 0.87 | 3.06 ± 0.79 | 0.343 |
| Total score | 19.06 ± 2.98 | 22.63 ± 2.68 | 0.025 |
Data are the mean of 8 replicates with 24 eggs each
Fig. 2Scaning electron micrograghs showing a mammillary view (a; magnification, 100×) of eggshell, normal mammillary body (b; 500×), early fusion of mammillary knobs (c; 500×) in young hen group (42 wk. of age) and late fusion of mammillary knobs (d; 500×) in aged hen group (72 wk. of age)
Comparison of the contents of proinflammatory cytokines in uterine mucosa between young (42 wk. of age) and aged hen groups (72 wk. of age)
| Items | Young hen | Aged hen | |
|---|---|---|---|
| IL-1β (pg/mg protein) | 7.47 ± 0.57 | 8.17 ± 0.47 | 0.019 |
| IL-6 (pg/mg protein) | 0.33 ± 0.04 | 0.36 ± 0.05 | 0.155 |
| IFN-γ (pg/mg protein) | 0.78 ± 0.07 | 0.82 ± 0.09 | 0.348 |
Data are the mean of 8 replicates with 2 birds each (one sample from the aged hen group was rejected due to no egg with incomplete shell present in hen oviduct)
Fig. 3The differentially expressed genes (DEGs; |fold change| > 1.5 at a false discovery rate (FDR) < 0.05; a) and the differentially expressed volcano diagram (b) of uterus in aged hen group (72 wk. of age) relative to young hen group (42 wk. of age)
Fig. 4Validation of the differentially expressed genes (DEGs) by RT-qPCR. a Fold change of transcriptome results for DEGs in aged hen group (72 wk. of age) relative to young hen group (42 wk. of age). b Relative mRNA expression of the DEGs. BF2, MHC class I antigen BF2; SLC9A9, solute carrier family 9 member A9; MHCIA6, major histocompatibility complex, class I, A6; YF5, MHC class I α-chain; VCAN, versican; CDH6, cadherin-6; OVAL, ovalbumin; PLCL1, phospholipase C like 1. Values are means and standard deviations represented by vertical bars and the values with asterisks mean significant difference between groups (P < 0.05)
Fig. 5Gene Ontology classification analysis of differentially expressed genes of uterus in age hen group (72 wk. of age) relative to young hen group (42 wk. of age)
Fig. 6Pathway analysis of differential expressed genes of uterus in aged hen group (72 wk. of age) relative to young hen group (42 wk. of age). The differential expressed genes in aged hen group relative to young hen group were only enriched (Q < 0.05) in the peroxisome proliferator-activated receptor (PPAR) signaling pathway (rich factor = 8.90)
Gene oncology (GO) clustering analysis of differentially expressed genes (DEGs; |fold change| > 1.5 at a false discovery rate < 0.05)
| GO Terms | GO.ID | Number of DEGs | |
|---|---|---|---|
| antigen processing and presentation of peptide antigen via MHC class I | GO:0002474 | 4 | < 0.001 |
| positive regulation of T cell mediated cytotoxicity | GO:0001916 | 4 | < 0.001 |
| regulation of catabolic process | GO:0009894 | 2 | 0.005 |
| antigen processing and presentation | GO:0019882 | 5 | 0.006 |
| protein ubiquitination involved in ubiquitin-dependent protein catabolic process | GO:0071947 | 2 | 0.011 |
| protein modification by small protein conjugation or removal | GO:0070647 | 5 | 0.016 |
| cellular protein modification process | GO:0006464 | 10 | 0.043 |
| protein modification process | GO:0036211 | 10 | 0.043 |
| macromolecule modification | GO:0043412 | 10 | 0.045 |
| MHC class I protein complex | GO:0042612 | 4 | < 0.001 |
| membrane | GO:0016020 | 41 | < 0.001 |
| integral component of membrane | GO:0016021 | 25 | < 0.001 |
| mitochondrion | GO:0005739 | 4 | 0.001 |
| cytoplasmic part | GO:0044444 | 16 | 0.004 |
| endomembrane system | GO:0012505 | 8 | 0.016 |
| membrane part | GO:0044425 | 34 | 0.026 |
| endosome | GO:0005768 | 3 | 0.029 |
| intrinsic component of membrane | GO:0031224 | 27 | 0.042 |
| extracellular matrix | GO:0031012 | 3 | 0.043 |
| peptide antigen binding | GO:0042605 | 4 | < 0.001 |
| catalytic activity | GO:0003824 | 29 | < 0.001 |
| identical protein binding | GO:0042802 | 2 | 0.004 |
| transferase activity | GO:0016740 | 11 | 0.005 |
| antigen binding | GO:0003823 | 4 | 0.005 |
| calcium ion binding | GO:0005509 | 5 | 0.008 |
| adenyl ribonucleotide binding | GO:0032559 | 3 | 0.015 |
| ATP binding | GO:0005524 | 3 | 0.015 |
| ion binding | GO:0043167 | 31 | 0.018 |
| adenyl nucleotide binding | GO:0030554 | 3 | 0.018 |
| oxidoreductase activity | GO:0016491 | 3 | 0.020 |
| oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | GO:0016705 | 2 | 0.026 |
| voltage-gated calcium channel activity | GO:0005245 | 2 | 0.047 |
Analysis of differentially expressed genes (|fold change| > 1.5 at a false discovery rate < 0.05) in association with matrix protein, calcium transport, immune response and defense mechanism
| Potential function | Gene (Fold change) | Annotation |
|---|---|---|
| Matrix protein | VCAN (1.55) | Versican, chondroitin sulfate proteoglycan, calcium ion binding |
| CDH6 (1.71) | Cadherin 6, calcium binding, in association with the physiological control of bone remodeling | |
| LOC107056462 (1.61) | Alpha-actinin-1-like, calcium binding | |
| PLCL1 (1.61) | Phospholipase C like 1, calcium binding | |
| OVAL (1.52) | Ovalbumin, regulate shell structure and present in eggshell | |
| GPC3 (0.64) | Glypican 3, regulate the activity of bone morphogenetic proteins and promote bone formation | |
| DMP1 (0.66) | Dental matrix protein-1, in association with tissue mineralization | |
| Calcium transport | CACNA1C (1.79) | Voltage-dependent L-type calcium channel subunit alpha-1C, ion transport protein, voltage-gated calcium channel activity |
| CACNA1D (1.68) | Voltage-dependent L-type calcium channel subunit alpha-1D, ion transport protein, voltage-gated calcium channel activity | |
| NMUR2 (1.52) | Thyrotropin-releasing hormone receptor, calcium ion transport | |
| Immune response | BF2 (0.66) | MHC class I antigen BF2, antigen processing and presentation |
| MHCIA5 (0.58) | Major histocompatibility complex, class I, A5, antigen processing and presentation | |
| MHCIA6 (0.62) | Major histocompatibility complex, class I, A6, antigen processing and presentation | |
| YF5 (0.64) | MHC class I antigen YF5, antigen processing and presentation | |
| LOC101748499 (1.64) | Class II histocompatibility antigen, B-L beta chain-like, immune response | |
| IL7 (1.63) | Interleukin 7, a cytokine important for B and T cell development | |
| C7 (1.61) | Complement C7, as part of the terminal complement pathway of the innate immune system | |
| KCTD7 (1.71) | Potassium channel tetramerization domain containing 7, negative regulation of inflammation | |
| Defense mechanism | ABCA13 (1.65) | ATP-binding cassette, sub-family A, membrane 13, defense mechanism |
| LOC107056420 (1.50) | Intestinal mucin-like protein, defense mechanism |